Pulike Biological Engineering, Inc. (SHA:603566)

China flag China · Delayed Price · Currency is CNY
12.01
-0.44 (-3.53%)
Apr 29, 2026, 3:00 PM CST
-9.02%
Market Cap 4.11B
Revenue (ttm) 1.09B
Net Income (ttm) 184.99M
Shares Out 341.92M
EPS (ttm) 0.54
PE Ratio 22.24
Forward PE 17.41
Dividend 0.40 (3.21%)
Ex-Dividend Date Oct 17, 2025
Volume 8,244,493
Average Volume 3,837,425
Open 12.20
Previous Close 12.45
Day's Range 11.67 - 12.20
52-Week Range 11.67 - 15.79
Beta 0.54
RSI 34.17
Earnings Date Apr 29, 2026

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 1,551
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603566
Full Company Profile

Financial Performance

In 2025, SHA:603566's revenue was 1.09 billion, an increase of 4.54% compared to the previous year's 1.04 billion. Earnings were 184.99 million, an increase of 99.33%.

Financial Statements

News

There is no news available yet.